Publication | Open Access
Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene.
330
Citations
48
References
1987
Year
OncologyHuman Mammmary TumorsOncogenic AgentMedicineC-erba OncogeneHuman Neu OncogenePathologyCancer GenomicsBreast CancerHigh FrequencyNeu Amplification PointsCancer GeneticsGene ExpressionCancer BiologyCell BiologyTumor SuppressorTumor Biology
We investigated alterations in the structure and expression of oncogenes in mammary tumors and mammary tumor-derived cell lines. In 16 of 95 samples, we detected amplification of the human neu oncogene, also known as c-erB-2, accompanied by overexpression in the tumors from which intact RNA could be isolated. In 10 of these DNAs, the linked oncogene c-erbA was also amplified, whereas another gene on human chromosome 17, p53, was present in normal copy numbers. Overexpression of c-erbA could not be detected in the tumors analyzed. The relatively high frequency of neu amplification points to a functional role in human breast cancer. Coamplification of the c-erbA oncogene could contribute to this disease as well but is most likely fortuitous.
| Year | Citations | |
|---|---|---|
Page 1
Page 1